Israel-based Teva Pharmaceutical Industries Ltd. will release its first quarter of 2003 financial results on Thursday, May 1, 2003. Teva is among the top 35 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.
Over 90 percent of Teva's sales are in North America and Europe. The company develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. — (menareport.com)
© 2003 Mena Report (www.menareport.com)
